Skip to content

A phase 1 study of oral Debio 0123 in combination with carboplatin in patients with advanced solid tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-510984-52-00
Acronym
Debio0123-101
Enrollment
115
Registered
2024-05-23
Start date
2019-05-24
Completion date
2025-10-23
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with tumors

Interventions

None listed

Sponsors

Debiopharm International SA
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026